Cannabis has generally been associated with adverse cardiovascular outcomes in observational research. In a 14-day randomized crossover trial, habitual cannabis users experienced fewer premature atrial contractions during cannabis-use periods despite no significant changes in activity, sleep, or glucose measures.
Clinical Considerations
- Premature atrial contractions fell by approximately 9% on cannabis-use days compared with abstinence days.
- Reduced ectopy was driven by fewer premature atrial contractions (PACs), a recognized predictor of atrial fibrillation.
- No significant differences emerged in premature ventricular contractions, sleep duration, glucose levels, or physical activity.
- Investigators emphasized the trial does not establish cardiovascular benefit and was not designed to assess long-term health outcomes.
Practice Applications
- Recognize that randomized physiologic findings may differ from observational cardiovascular risk studies.
- Interpret reductions in PAC frequency separately from long-term cardiovascular outcome questions.
- Avoid framing these findings as evidence supporting cannabis use for cardiac health.
- Monitor emerging mechanistic research exploring determinants of atrial ectopy and arrhythmia risk.
PATIENT EDUCATION
OBESITY/WEIGHT MANAGEMENT
EXERCISE/TRAINING
LEGAL MATTERS
GUIDELINES/RECOMMENDATIONS